2,2-Dimethyl-propionic acid 6,6-dimethyl-4-oxo-bicyclo[3.1.1]hept-2-en-2-ylmethyl ester | 186607-85-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 2,2-Dimethyl-propionic acid 6,6-dimethyl-4-oxo-bicyclo[3.1.1]hept-2-en-2-ylmethyl ester
• 英文别名: (6,6-Dimethyl-4-oxo-2-bicyclo[3.1.1]hept-2-enyl)methyl 2,2-dimethylpropanoate
• CAS: 186607-85-2
• 化学式: C₁₅H₂₂O₃
• 分子量: 250.338
• InChiKey: NJIUSKQTOGHXSZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2,2-Dimethyl-propionic acid 6,6-dimethyl-4-oxo-bicyclo[3.1.1]hept-2-en-2-ylmethyl ester 生成 4-hydroxymyrtenyl pivalate
  参考文献：
  名称：

  Mechoulam; Breuer; Feigenbaum, Il Farmaco, 1991, vol. 46, # SUPPL. 1, p. 267 - 276

  摘要：

  DOI：
• 作为产物：
  描述：

  桃金娘烯醇 生成 2,2-Dimethyl-propionic acid 6,6-dimethyl-4-oxo-bicyclo[3.1.1]hept-2-en-2-ylmethyl ester
  参考文献：
  名称：

  Mechoulam; Breuer; Feigenbaum, Il Farmaco, 1991, vol. 46, # SUPPL. 1, p. 267 - 276

  摘要：

  DOI：

文献信息

• [EN] PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CANNABINOID COMPOUNDS<br/>[FR] PROCÉDÉ POUR LA PRÉPARATION DE COMPOSÉS CANNABINOÏDES 3-SUBSTITUÉS
  申请人：E-THERAPEUTICS PLC

  公开号：WO2017093749A1

  公开（公告）日：2017-06-08

  There is described a method of preparing a compound of formula I, and optical isomers thereof: in which R1 is hydrogen or a protecting group; said method comprising oxidising verbenone and optical isomers thereof.

  本文描述了一种制备化合物I及其光学异构体的方法：其中R1为氢或保护基；该方法包括氧化薄荷酮和其光学异构体。
• [EN] METHODS, PROCESSES, AND COMPOSITIONS FOR IMPROVED PREPARATION OF HU308 AND HU433<br/>[FR] MÉTHODES, PROCÉDÉS ET COMPOSITIONS POUR UNE PRÉPARATION AMÉLIORÉE DE HU308 ET DE HU433
  申请人：TETRA BIO PHARMA INC

  公开号：WO2022061461A1

  公开（公告）日：2022-03-31

  Disclosed herein are methods, processes and compositions for preparing a compound of formula 8: (8), and formula 18: (18). The methods and processes comprise performing a first allylic oxidation, a protection reaction, a second allylic oxidation, a reduction reaction, performing an acid-catalyzed coupling reaction, a methylation reaction and a deprotection reaction. Disclosed herein are methods, processes and compositions for enantioselectively preparing compounds of formulae 8 and 18. Also disclosed herein are compositions comprising compounds of formulae 8, 18 and/or intermediates and/or starting material thereof.

  本文揭示了制备化合物式8和式18的方法、工艺和组合物。该方法和工艺包括进行第一次烯丙基氧化反应、保护反应、第二次烯丙基氧化反应、还原反应、进行酸催化偶联反应、甲基化反应和去保护反应。本文还揭示了对化合物式8和18进行对映选择性制备的方法、工艺和组合物。本文还揭示了包含化合物式8、18和/或其中间体和/或起始材料的组合物。
• High enantiomeric purity dexanabinol for pharmaceutical compositions
  申请人：Aviv Haim

  公开号：US20070060636A1

  公开（公告）日：2007-03-15

  The present invention relates to a synthetic cannabinoid, dexanabinol, of enantiomeric purity in excess of 99.90%, or to a pharmaceutically acceptable salt, ester or solvate of said compound. The present invention also relates to pharmaceutical grade compositions comprising said compound of high enantiomeric purity, and uses thereof for prevention and treatment of neurological disorders, chronic degenerative diseases, CNS poisoning, cognitive impairment, inflammatory diseases or disorders, autoimmune diseases or disorders, pain, emesis, glaucoma and wasting syndromes.

  本发明涉及一种合成大麻素，即左旋丙氨酸酯，其对映异构体纯度超过99.90％，或该化合物的药学上可接受的盐，酯或溶剂。本发明还涉及包含高对映异构体纯度的该化合物的制药级组合物，以及用于预防和治疗神经系统疾病，慢性退行性疾病，中枢神经系统中毒，认知障碍，炎症性疾病或紊乱，自身免疫疾病或紊乱，疼痛，呕吐，青光眼和消耗综合征的用途。
• MECHOULAM, RAPHAEL;FEIGENBAUM, JEFFRY;SREBNIK, MORRIS;LANDER, NAFTALL
  作者：MECHOULAM, RAPHAEL、FEIGENBAUM, JEFFRY、SREBNIK, MORRIS、LANDER, NAFTALL

  DOI：——

  日期：——
• COMPOSITIONS COMPRISING CB RECEPTOR AGONISTS, USES THEREOF AND METHODS FOR THEIR PREPARATION
  申请人：Bab Itai

  公开号：US20110269842A1

  公开（公告）日：2011-11-03

  Provided are compositions including (3R, 4R, 6R)-stereoisomers of phenyl substituted pinenes having CB receptor agonist properties, methods of treating diseases or disorders with the pharmaceutical compositions, and processes for their preparation are also provided.